| My Account | Subscribe | Contact Us | Donate |
Rachel and her husband chose to adopt a baby instead of meeting the challenges of handling a high risk pregnancy and Rachel’s type 1 diabetes at the same time. She shares their thought process and ultimate happy ending about the decision to bring a child into their lives.
Hosting Hardball on MSNBC and The Chris Matthews Show keep Chris Matthews working long hours. But Matthews got a lesson in priorities and made some life changes when he was diagnosed with type 2.
Olivia and her dog both have diabetes and today they comfort and encourage each other through the rigors of dealing with the disease. Plus, find out what it means when your domestic pet is diagnosed with diabetes.
Smoking has severe effects on your diabetes and your health. Learn why diabetes and smoking are an especially bad combination and get some tips from the experts on how to quit.
CGM is a relatively new technology, but the information it provides is invaluable. Find out what CGM offers and whether it could help you.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest Insulin Articles
A report published in the August 1992 issue of Diabetes Care predicts that the early morning high blood sugars (hyperglycemia) experienced by Type I diabetes patients could possibly be the result of their current insulin therapy. With a twice-daily dosage of combined human lente and regular insulin (HL/R) injections, blood sugar levels may rise from a lack of insulin early in the morning, when it is needed most.
Researchers from the Department of Pediatrics and Medicine at the Indiana University Medical Center, Indianapolis, compared the effects of human ultralente insulin (HUL) and human lente insulin on morning fasting blood glucose levels. The purpose of the study was to determine whether a twice-daily regimen of human ultralente insulin combined with regular insulin (HUL/R) would improve raised morning blood sugar levels and metabolic control in children with Type I diabetes.
The researchers developed a twice-daily injection regimen using HUL insulin in their study. The authors of the report note that since HUL insulin has a longer duration and a diminished peak, it would increase the amount of insulin available in the early morning hours.
Thirty-one children with Type I diabetes were selected to carry out the study. After continuing the patients on four more weeks of HL/R injections, the researchers split the group into HUL/R insulin users and HL/R insulin users. The trial lasted for twelve weeks, with each patient taking an injection once before breakfast and once before the evening meal.
After the twelve week trial, the researchers concluded that young Type I diabetes patients using twice-daily doses of human ultralente (HUL) insulin combined with regular insulin can safely improve fasting blood glucose levels and lower the magnitude of the morning glucose rise. HUL/R did not improve metabolic control.
Categories: Insulin
Email to a Friend
Send a link to this page to your friends and colleagues.